ReviewBiomolecules2021
BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme.
Mary-Ann Xavier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewBiomolecules2021
Mary-Ann Xavier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.